Codi QR

Impact of first-trimester preeclampsia screening on perinatal and maternal morbidity: the RANSPRE open multicenter randomized trial

Abstract Background Preeclampsia (PE) affects 2–8% of pregnant women and is a leading cause of maternal and perinatal morbidity and mortality. In high-risk pregnant women, low-dose aspirin (LDA 100—160 mg/day) started before 16 WG reduces the incidence of PE, prematurity, perinatal mortality and low...

Descripció completa

Guardat en:
Autors principals: Vassilis Tsatsaris, Jean Guibourdenche, Catherine Deneux-Tharaux, on behalf of the RANSPRE Study Group
Format: Artigo
Idioma:Inglês
Publicat: BMC 2026-03-01
Col·lecció:BMC Pregnancy and Childbirth
Matèries:
PE
Early screening
Prevention
Aspirin
Perinatal mortality
Preterm delivery
Accés en línia:https://doi.org/10.1186/s12884-026-08920-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars